期刊文献+

高同型半胱氨酸血症与2型糖尿病视网膜病变的关系 被引量:4

高同型半胱氨酸血症与2型糖尿病视网膜病变的关系
在线阅读 下载PDF
导出
摘要 目的探讨2型糖尿病患者血浆同型半胱氨酸(homocysteine,Hcy)水平与糖尿病视网膜病变之间的关系。方法测定45例2型糖尿病(DM)患者及19例健康对照者(CON)血浆同型半胱氨酸水平,45例2型糖尿病患者分为糖尿病视网膜病变(DR)组(17例)与无视网膜病变(NDR)组(28例),比较各组间血浆总Hcy的水平;再将17例DR组分为增殖期糖尿病视网膜病变(PDR)组(9例)和背景期糖尿病视网膜病变(BDR)组(8例),比较两组间血浆总Hcy的水平。结果2型糖尿病患者中DR组的血浆总Hcy水平高于NDR组及CON组(P<0.01),NDR与CON组比较则无显著性差异。在DR组,PDR组的血浆总Hcy水平显著高于BDR组(P<0.01),以正常对照组的血浆Hcy均数+2个标准差作为高Hcy血症的诊断标准,PDR组高Hcy血症的发生率高于BDR组(P<0.05)。结论2型糖尿病患者伴有视网膜病变者血浆总Hcy水平升高,其中PDR组的血浆总Hcy又高于BDR组。血浆总Hcy水平升高,可能是2型糖尿病视网膜病变的危险因素之一。 Objective To explore the relationship between the lever of serum homocysteine (Hcy) and retinopathy in type 2 diabetes mellitus. Methods The level of serum homocysteine (Hcy) was measured in type 2 diabetes mellitus group of 45 and in healthy contrast group of 19. 45 cases were divided into diabetic retinopathy ( DR, 17 cases) and no - diabetic diabetic group (NDR, 28 cases). At the same time in DR group , 17 case were divided into proliferative phase DR group(PDR, 9 cases) and background DR group (BDR, 8 cases). Results The level of serum Hcy in DR group was higher than that of in NDR group and CON group respectively (p 〈 0.01) ,while there was no significant difference between NDR group and CON group .The level of serum Hcy in PDR group was higher than that of in BDR group (p 〈 0.01 ). Conclusion The level of serum Hcy was increased in type 2 diabetes mellitus combined with retinopathy and it maybe one of risk factor for 2 diabetes mellitus to develop retinopathy.
出处 《浙江临床医学》 2005年第9期907-908,共2页 Zhejiang Clinical Medical Journal
  • 相关文献

参考文献9

  • 1王绵,李凤英,葛秀兰.高同型半胱氨酸血症与胰岛素抵抗及糖尿病慢性并发症[J].国外医学(内分泌学分册),2001,21(3):146-149. 被引量:46
  • 2Hofmann MA, Amiral J, Kohl B,et al.Hyperhomocyst(e) inemia and endothelial dysfunction in IDDM. Diabetes Care,1997,20:1880.
  • 3Looker HC,Fagot-Campagna A,Gunter EW, et al.Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia,2003,46(6):766~772.
  • 4Stabler S P, Estacio Jeffers,B W. Total homocysteine is associated with niphropathy in non-insulin-dependent diabetes mellitus. Metabolism,1999,48:1096~1101.
  • 5Smulders YM, Rakic M, Slaats EH, et al.Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy,albuminuria,and cardiovascular disease.Diabetes Care,1999,22:125~132.
  • 6Munshi MN, Stone A, Fink L, et al. Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes millitus and macrovascular disease. Metabolism,1996,45:133~135.
  • 7郭雪微,张鑫生.同型半胱氨酸导致阻塞性血管疾病的机理[J].中国老年学杂志,2001,21(2):158-159. 被引量:18
  • 8Blom HJ, Kleinveld HA, Boers GH,et al.Lipid peroxidation and susceptibility of low-density lipopretein to in vitro oxidation in hyperhomocysteinaemia. Eur J Clin Invest,1995,25:149~154.
  • 9DiMinno G, Davi G, Margaglione M, et al. Abnormally high thromboxane biosynthesis in homozygous homocysteinuria: Evidence for platelet involvoment and probucol-sensitive mechanism. J Clin Invest,1993,92(10):1400~1406.

二级参考文献7

  • 1Dudman N P,Circulation Research,1999年,4卷,84期,409页
  • 2Harpel P C,J Nutr,1996年,126卷,1285s页
  • 3Tsai J C,Proc Natl Acad Sci USA,1994年,91卷,6369页
  • 4Di Minnog,J Clin Invest,1993年,92卷,1400页
  • 5Dudman N P,Atherosclerosis,1991年,91卷,77页
  • 6Lentz S R M,J Clin Invest,1991年,88卷,1906页
  • 7A. Chico,A. Pérez,A. Córdoba,R. Arcelús,G. Carreras,A. de Leiva,F. González-Sastre,F. Blanco-Vaca. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?[J] 1998,Diabetologia(6):684~693

共引文献59

同被引文献29

  • 1卜瑞芳,邓振霞,沈泓,许岚,吴懿玲,蒋艳敏,华嘉临,张稷.血浆同型半胱氨酸水平与2型糖尿病合并脑梗死的关系[J].中华内分泌代谢杂志,2004,20(5):444-445. 被引量:39
  • 2陆菊明,谷伟军.同型半胱氨酸与糖尿病及其血管并发症的关系[J].中华老年医学杂志,2005,24(6):472-472. 被引量:16
  • 3刘伟峰,张步延,黄文增,关红菁.高同型半胱氨酸血症致血管炎症作用[J].中国动脉硬化杂志,2005,13(4):464-466. 被引量:32
  • 4Buysschaert M, Dramais AS,Wallemacq PE, et al. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy and insulin resistance [ J ]. Diabetes Care, 2000,23 ( 11 ) : 1816 -1822.
  • 5Scoot CH, Sutton MS. Homocysteine:evidence for a causal relationship with cardiovascular disease[J]. Cardiol Rev, 1999,7(2) :101-107.
  • 6Barbe F, Klein M, Chango A, et al.Homocysteine folate vitamin B12 and transcobalamins in patients undergoing successive hypo and hyper- thyroid StatesJ Clin EndoerinolMetab, 2001,86:1845.
  • 7Diekman MJ,Vanderput NM, Blom H.I, et al.Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol(Oxf), 2001,54:197.
  • 8Okada E, Tohda G, Oida K, et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2diabetes. Diabetes Care, 1999, 22: 484.
  • 9Buysschaert M, Dramais AS,Wallemacq PE, et al. Hyperhomocysteinemia in type 2 diabetes:relationship to macroangiopathy, nephropathy and insulin resistance.Diabetes Care, 2000, 23 (11):1816-1822.
  • 10Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death : the Vi- tamin Intervention for Stroke Prevention(VISP) random ized controlled trial[J]. JAMA, 2004,291 (5) : 565-575.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部